[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 110
Citations 0
Comment & Response
September 2016

Stent Retrievers for Treating Anterior Circulation Acute Ischemic Stroke—Reply

Author Affiliations
  • 1Division of Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital/McGill University, Montreal, Quebec, Canada
  • 2Faculty of Medicine, McGill University, Montreal, Quebec, Canada
  • 3Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
  • 4Department of Medicine, McGill University, Montreal, Quebec, Canada
  • 5Division of Cardiology, Jewish General Hospital/McGill University, Montreal, Quebec, Canada
JAMA Neurol. 2016;73(9):1155-1156. doi:10.1001/jamaneurol.2016.2204

In Reply We thank Bianchin and colleagues for their interest in our systematic review and meta-analysis.1 The objective of our study was to synthesize the available evidence to determine the overall risks and benefits of stent retrievers in the treatment of acute ischemic stroke (AIS). To do so, we included all available randomized clinical trials comparing the use of stent retrievers in conjunction with recombinant tissue plasminogen activator vs recombinant tissue plasminogen activator alone, regardless of AIS location. However, all of the available randomized clinical trials restricted inclusion to patients with AIS of the anterior circulation.

First Page Preview View Large
First page PDF preview
First page PDF preview
×